论文部分内容阅读
根据中国药学会1987年学术活动计划,由主办单位中国药学会药物分析学会和协作单位中国药品生物制品检定所组成的“新药审批演讲团”,受中国药学会陕西分会的邀请,定于今年七月上旬来西安,为西北及河南等六省(区)从事新药研究、教学、生产、检验、监督管理等专业的中、高级科技人员举办“新药申报研究班”。届时将由卫生部新药审评委员会办公室副主任、副主任药师朱燕、主任药师杨伯群、副主任药师赵秀文、主管药师杨兆起等分别讲授新药审批办法总论、药理、药效、化学药品与质量标准、中药等有关内容。
According to the 1987 academic activity plan of Chinese Pharmaceutical Association, the “New Drug Examination and Approval Lecture Group” consisting of the Institute of Pharmaceutical Analysis of the Chinese Pharmaceutical Association and the cooperating unit of China Pharmaceutical and Biological Products Agency, sponsored by the Chinese Pharmacological Society Shaanxi Branch, is scheduled for this year’s seven In early January, he came to Xi’an to hold a “New Drug Declaration Seminar” for middle and senior scientific and technical personnel engaged in the research, teaching, production, inspection, supervision and management of new drugs in the six provinces (autonomous regions) such as the Northwest and Henan. By the new drug review and Adjudication Board Office of the Ministry of Health, deputy director, deputy director Zhu Yan, chief pharmacist Yang Boqun, deputy director of pharmacists Zhao Xiuwen, in charge of pharmacist Yang Zhaoqi, respectively, to review the new drug approval methods, pharmacology, pharmacodynamics, chemicals and quality standards , Chinese medicine and other related content.